Isracann Biosciences Inc.
ISCNF · OTC
5/31/2022 | 5/31/2021 | 5/31/2020 | 5/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $214 | $1,958 | $3,891 | $4,178 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $83 | $208 | $243 | $16 |
| Inventory | $0 | $0 | -$243 | $0 |
| Other Curr. Assets | $48 | $84 | $1,587 | $11,255 |
| Total Curr. Assets | $345 | $2,251 | $5,478 | $15,449 |
| Property Plant & Equip (Net) | $48 | $89 | $117 | $893 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $3,698 | $3,698 | $20,619 | $20,619 |
| Long-Term Investments | $0 | $254 | $269 | $0 |
| Tax Assets | $0 | -$3,698 | $0 | $0 |
| Other NC Assets | $0 | $1,806 | $1,791 | -$20,589 |
| Total NC Assets | $3,746 | $2,149 | $22,796 | $923 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $4,091 | $4,400 | $28,274 | $16,372 |
| Liabilities | – | – | – | – |
| Payables | $306 | $450 | $705 | $935 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $609 | $15 | $1,013 | $105 |
| Total Curr. Liab. | $915 | $465 | $1,718 | $1,039 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2,885 | $0 | $0 | $0 |
| Total NC Liab. | $2,885 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $3,800 | $465 | $1,718 | $1,039 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $62,867 | $62,012 | $56,894 | $11,744 |
| Retained Earnings | -$76,822 | -$72,129 | -$43,786 | -$19,588 |
| AOCI | $14,120 | $14,056 | $13,451 | $13,067 |
| Other Equity | $130 | $0 | $0 | $10,110 |
| Total Equity | $294 | $3,938 | $26,559 | $15,333 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$3 | -$3 | -$3 | $0 |
| Total Liab. & Tot. Equity | $4,091 | $4,400 | $28,274 | $16,372 |
| Net Debt | -$214 | -$1,958 | -$3,891 | -$4,178 |